文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Aa Zalutskaya
发表
Abstract OT3-06-01: SHERBOC: A double-blind, placebo-controlled, phase 2 trial of seribantumab (MM-121) plus fulvestrant in postmenopausal women with hormone receptor-positive, heregulin positive, HER2 negative metastatic breast cancer whose disease progressed after prior systemic therapy
Hong Zhang, T. Bloom, G. Finn, 2018 .